John S. Mitcheson
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Role of beta-adrenergic modulation of action potential duration in arrhythmogenesis in Long QT Syndrome Type 1 & 2.
Journal: Autonomic neuroscience : basic & clinical
Published: January 26, 2026
Correction: Discovery of a heme-binding domain in a neuronal voltage-gated potassium channel.
Journal: The Journal of biological chemistry
Published: March 05, 2022
Discovery of a heme-binding domain in a neuronal voltage-gated potassium channel.
Journal: The Journal of biological chemistry
Published: May 04, 2020
Author Correction: A mechanism for CO regulation of ion channels.
Journal: Nature communications
Published: August 19, 2018
A mechanism for CO regulation of ion channels.
Journal: Nature communications
Published: October 19, 2017
Modulation of hERG potassium channels by a novel small molecule activator.
Journal: British journal of pharmacology
Published: June 19, 2017
Calmodulin Regulates Human Ether à Go-Go 1 (hEAG1) Potassium Channels through Interactions of the Eag Domain with the Cyclic Nucleotide Binding Homology Domain.
Journal: The Journal of biological chemistry
Published: April 19, 2016
A heme-binding domain controls regulation of ATP-dependent potassium channels.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 24, 2016
hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes.
Journal: Therapeutic advances in drug safety
Published: August 25, 2015
hERG potassium channel inhibition by ivabradine requires channel gating.
Journal: Journal of molecular and cellular cardiology
Published: June 15, 2015
hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
Journal: Journal of the American Heart Association
Published: April 26, 2015
Last Updated: 09/26/2026